Back
ZyVersa Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
34
ZVSA
ZyVersa Therapeutics
Last Price:
$0.79
Seasonality Move:
-26.67%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVSA is experiencing slight selling pressure.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.68 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.63 | Buy |
| 200-day SMA: | 1.18 | Sell |
| 8-day EMA: | 0.68 | Sell |
| 20-day EMA: | 0.66 | Buy |
| 50-day EMA: | 0.68 | Sell |
| 200-day EMA: | 9.95 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 51.2 | Buy |
| Chaikin Money Flow: | -110894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ZyVersa Therapeutics Technical Analysis
| Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.67 while ZVSA 8-day simple moving average is 0.68, which is a Sell signal.
-
The stock price of ZVSA is 0.67 while ZyVersa Therapeutics 20-day SMA is 0.67, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 0.63 while ZVSA share price is 0.67, making it a Buy technically.
-
ZVSA stock price is 0.67 and ZyVersa Therapeutics 200-day simple moving average is 1.18, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
34
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.67. The Score for ZVSA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
3.2M
Price in USD:
0.67
Share Volume:
133.2K
ZyVersa Therapeutics 52-Week Range
52-Week High:
6.30
52-Week Low:
0.47
Sell
34
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.67 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.67 while ZVSA 8-day exponential moving average is 0.68, which is a Sell signal.
-
The stock price of ZVSA is 0.67 while ZyVersa Therapeutics 20-day EMA is 0.66, which makes it a Buy.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.68 while ZVSA share price is 0.67, making it a Sell technically.
-
ZVSA stock price is 0.67 and ZyVersa Therapeutics 200-day simple moving average is 9.95, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting ZyVersa Therapeutics is a Buy
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 51.2, which suggest ZyVersa Therapeutics is overbought
-
The Bollinger Bands (25) for ZyVersa Therapeutics is ( - ), which suggest ZyVersa Therapeutics is a Buy
-
The Bollinger Bands (100) for ZyVersa Therapeutics is ( - ), which suggest ZyVersa Therapeutics is a Buy
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.